Chiron Real Estate Inc. · NYSE:XRN
Chiron Real Estate — Global Medical REIT — Q2 2025 Earnings Presentation
23 slides from Chiron Real Estate's earnings presentation, Aug 6, 2025
Slide 1: Second Quarter 2025 Earnings Supplemental
Atrium Health – Winston-Salem, NC SECOND QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE
Slide 2: Table of Contents / Forward-Looking Statements
TABLE OF CONTENTS Company Overview 3 Select Quarterly Financial Data 6 Business Summary 7 Acquisitions / Dispositions 8 Portfolio Summary 9 Key Tenants 11 Debt and Hedging Summary 12 Total Capitalization and Equity 14 Summary Condensed Consolidated 15 Statements of Operations Condensed Consolidated
Slide 3: Company Overview
COMPANY OVERVIEW GLOBAL MEDICAL REIT INC. (GMRE) IS A NET-LEASE MEDICAL REAL ESTATE INVESTMENT TRUST (REIT) THAT ACQUIRES HEALTHCARE FACILITIES AND LEASES THOSE FACILITIES TO PHYSICIAN GROUPS AND REGIONAL AND NATIONAL HEALTHCARE SYSTEMS. Blue Sky Vision – Grand Rapids, MI PORTFOLIO SNAPSHOT (as of J
Slide 4: Company Overview
COMPANY OVERVIEW Executive Officers Mark Decker, Jr. Chief Executive Officer and President Robert Kiernan Chief Financial Officer and Treasurer Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Jamie Barber General Counsel and Corporate Secretary Board of Directors Jeffrey
Slide 5: Company Overview
COMPANY OVERVIEW Corporate Headquarters Global Medical REIT Inc. 7373 Wisconsin Avenue, Suite 800 Sell-Side Analyst Coverage Bethesda, MD 20814 Phone: 202.524.6851 www.globalmedicalreit.com Firm Name Stock Exchange Alliance Global Partners Guarav Mehta New York Stock Exchange Ticker: GMRE B Riley Jo
Slide 6: Select Quarterly Financial Data
SELECT QUARTERLY FINANCIAL DATA (unaudited, and in thousands, except per share and unit amounts) June 30, March 31, December 31, September 30, June 30, As of Period End (Unless Otherwise Specified) 2025 2025 2024 2024 2024 Market capitalization (common and OP) $479,022 $604,826 $533,568 $684,256 $61
Slide 7: Business Summary
BUSINESS SUMMARY SECOND QUARTER 2025 OPERATING SUMMARY • Net loss attributable to common stockholders was $0.8 million, or $0.01 per diluted share, as compared to $3.1 million, or $0.05 per diluted share, in the comparable prior year period. • Funds from operations attributable to common stockholder
Slide 8: Acquisitions / Dispositions
ACQUISITIONS / DISPOSITIONS (as of August 4, 2025) 2025 Acquisitions Completed To-Date Leasable Contractual Annualized Acquisition Square Purchase Price Base Rent* Capitalization Date Property City, State Feet (in thousands) (in thousands) Rate* 2/7/2025 St. Joseph's Medical Plaza Tucson, AZ 95,598
Slide 9: Portfolio Summary
PORTFOLIO SUMMARY (as of June 30, 2025) Texas Digestive Disease Consultants– Ft. Worth, TX PORTFOLIO STATISTICS St Joesph’s Medical Plaza – Tucson, AZ Gross Investment in Real Estate (in billions) $1.5 Total Buildings 193 Total Leasable Square Feet (in millions) 5.2 Total Tenants 319 Leased Occupanc
Slide 10: Portfolio Summary
PORTFOLIO SUMMARY (as of June 30, 2025) Lease Expiration Schedule (ABR in thousands) Leasable % of Total Leasable % of Total Year # of Leases Square Feet Square Feet ABR* ABR* 2025 22 85,149 1.6% $1,668 1.4% 2026 86 603,522 11.6% $12,742 10.8% 2027 59 546,262 10.5% $12,509 10.6% 2028 54 307,648 5.9%
Slide 11: Key Tenants
KEY TENANTS Asset Type % of Portfolio ABR* LifePoint Health operates 60 community hospital campuses, more than 60 rehabilitation and behavioral health hospitals and more than 250 additional sites of IRF 6.9% care, including managed acute rehabilitation units, outpatient centers and post-acute care f
Slide 12: Debt and Hedging Summary
DEBT AND HEDGING SUMMARY Debt Statistics As of June 30, 2025 Total Gross Debt (in thousands) $716,757 Fixed Rate Debt-to-Total Debt 72% Weighted Average Interest Rate 4.09% Weighted Average Maturity 1.6 years Leverage Ratio* 47.2% Fixed Charge Coverage Ratio for Quarter (1.5x minimum)* 2.63 Debt Det
Slide 13: Debt and Hedging Summary
DEBT AND HEDGING SUMMARY Citrus Valley Medical Associates – Corona, CA Interest Rate Swap Detail (as of June 30, 2025) (1) Notional Term Weighted Average Interest Rates Term Loan A - $350,000 Current – 4/2026 Fixed base rate: 1.36% Effective interest rate: 2.95%(2) Term Loan B - $150,000 Current – 2
Slide 14: Total Capitalization and Equity Summary
TOTAL CAPITALIZATION AND EQUITY SUMMARY (unaudited, and in thousands, except per share data) Total Capitalization As of June 30, 2025 Total Gross Debt $716,757 Preferred Stock $74,959 Common Stock (66,879 shares)(1) $463,471 OP Units (2,244 units)(1) $15,551 Vested LTIP Units (2,850 units)(2) $— Tot
Slide 15: Condensed Consolidated Statements of Operations
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited, and in thousands, except per share amounts) Three Months Ended Six Months Ended June 30, June 30, 2025 2024 2025 2024 Revenue Rental revenue $ 37,880 $ 34,214 $ 72,475 $ 69,283 Other income 89 27 112 77 Total revenue 37,969 34,241 72,587 69
Slide 16: Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, and in thousands) As of June 30, 2025 December 31, 2024 Assets Investment in real estate: Land $ 173,123 $ 174,300 Building 1,095,324 1,044,019 Site improvements 24,966 23,973 Tenant improvements 80,019 69,679 Acquired lease intangible assets 147,376
Slide 17: Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, and in thousands) Six Months Ended June 30, 2025 2024 Operating activities Net income $ 4,322 $ 362 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation expense 21,614 20,240 Amortization of acquire
Slide 18: Non-GAAP Reconciliations - FFO / AFFO / FAD
NON-GAAP RECONCILIATIONS - FFO / AFFO / FAD* (unaudited, and in thousands, except per share and unit amounts) Three Months Ended June 30, March 31, December 31, September 30, June 30, FFO and AFFO 2025 2025 2024 2024 2024 Net income (loss) $ 585 $ 3,737 $ 2,939 $ 3,391 $ (1,952) Less: Preferred stoc
Slide 19: Non-GAAP Reconciliations – EBITDAre / Adjusted EBITDAre
NON-GAAP RECONCILATIONS – EBITDAre / ADJUSTED EBITDAre* (unaudited, and in thousands, except per share and unit amounts) Three Months Ended June 30, March 31, December 31, September 30, June 30, EBITDAre and Adjusted EBITDAre 2025 2025 2024 2024 2024 Net income (loss) $ 585 $ 3,737 $ 2,939 $ 3,391 $
Slide 20: Sustainability Summary
SUSTAINABILITY SUMMARY ENVIRONMENTAL • We take climate change, and the risks associated with climate change, seriously—both physical and transitional. We utilized Moody’s 427 Risk Management platform to help us identify and measure the potential climate risk exposure for our properties. The analysis
Slide 21: Reporting Definitions and Other Disclosures
REPORTING DEFINITIONS AND OTHER DISCLOSURES Annualized Base Rent Annualized base rent represents monthly base rent for June 2025 (or, for recent acquisitions, monthly base rent for the month of acquisition), multiplied by 12 (or base rent net of annualized expenses for properties with gross leases).
Slide 22: Reporting Definitions and Other Disclosures
REPORTING DEFINITIONS AND OTHER DISCLOSURES Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (“EBITDAre” and “Adjusted EBITDAre”) We calculate EBITDAre in accordance with standards established by NAREIT and define EBITDAre as net income or loss computed in accordance wi
Slide 23: Investor Relations
INVESTOR RELATIONS Contact: investors@globalmedicalreit.com 202.524.6869 globalmedicalreit.com NYSE: GMRE